Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

PSYENCE GROUP Aktie

>PSYENCE GROUP Performance
1 Woche: 0%
1 Monat: 0%
3 Monate: 0%
6 Monate: -29,7%
1 Jahr: 0%
laufendes Jahr: 0%
>PSYENCE GROUP Aktie
Name:  PSYENCE GROUP INC. NEW
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA74449Q2053 / A416VT
Symbol/ Ticker:  EKW0 (Frankfurt)
Kürzel:  FRA:EKW0, ETR:EKW0, EKW0:GR
Index:  -
Webseite:  https://psyence.com/
Profil:  Psyence Group Inc. is a Canadian life science biotechnology company specializing in the research, cultivation, and production of natural psychedelics and nature-based compounds aimed primarily at mental health applications. Founded in 2019 and headqu..
>Volltext..
Marktkapitalisierung:  1.15 Mio. EUR
Unternehmenswert:  0.83 Mio. EUR
Umsatz:  -
EBITDA:  -2.17 Mio. EUR
Nettogewinn:  -7.61 Mio. EUR
Gewinn je Aktie:  -0.62 EUR
Schulden:  -
Liquide Mittel:  0.33 Mio. EUR
Operativer Cashflow:  -2.56 Mio. EUR
Bargeldquote:  10.12
Umsatzwachstum:  -
Gewinnwachstum:  81.32%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  PSYENCE GROUP
Letzte Datenerhebung:  05.04.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 15.64 Mio. St.
Frei handelbar: 97.32%
Leerverk. Aktien: -
Rückkaufquote: -390.38%
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Neutral
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: -
KBV: 2.23
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -
Gewinnmarge: -
Operative Marge: -
Managementeffizenz:
Gesamtkaprendite: -485.54%
Eigenkaprendite: -
>Peer Group
Gesundheit, Neurologische- & psychische Behandlung/ Medizin, Nahrungsergänzungsmittel & Wellnessprodukte
 
25.03.26 - 00:06
Psyence Group Inc.: Psyence Group Announces GoldCoast Resource Closes Second Tranche of Offering (Accesswire)
 
Combined aggregate with previous tranche of $8,603,883 TORONTO, ON / ACCESS Newswire / March 24, 2026 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") announces that GoldCoast Resource ......
24.02.26 - 12:06
Psyence Group Inc. Enters into Amending Agreement to Extend Amalgamation Timeline with GoldCoast Resource Corp. (Accesswire)
 
TORONTO, ON / ACCESS Newswire / February 24, 2026 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") announces that it has entered into an amending agreement (the "Amending Agreement") da......
27.01.26 - 16:06
Psyence Group Inc.: Psyence Group′s RTO Target, GoldCoast Resource Corp., Granted Offshore Reconnaissance License for Gold Exploration on Ghana′s Shallow Continental Shelf (Accesswire)
 
TORONTO, ON / ACCESS Newswire / January 27, 2026 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") announces that its proposed reverse takeover target, GoldCoast Resource Corp. ("GoldCoa......
25.11.25 - 08:33
XFRA: EKW0: Aussetzung/Suspension (XETRA)
 
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL PSYENCE GROUP INC. NEW EKW0 CA74449Q2053 BAW/UFN...
25.11.25 - 08:03
XFRA: INSTRUMENT_SUSPENSION - CA74449Q2053 (XETRA)
 
Instrument ID [23657355] (EKW0 - CA74449Q2053) suspended...
24.11.25 - 22:54
CSE Bulletin: Halted for Fundamental Change - Psyence Group Inc. (PSYG) (Newsfile)
 
Toronto, Ontario--(Newsfile Corp. - Le 24 novembre/November 2025) - Trading in the shares of Psyence Group Inc. (PSYG) will remain halted pending receipt and review of acceptable documentation reg......
24.11.25 - 19:30
Psyence Group Inc. Enters into Amalgamation Agreement with Goldcoast Resource Corp. (Accesswire)
 
TORONTO, ON / ACCESS Newswire / November 24, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") is pleased to announce that, further to its news release dated August 22, 2025, it has......
17.10.25 - 22:18
Psyence Group Inc. Announces RSU Grants (Accesswire)
 
TORONTO, ON / ACCESS Newswire / October 17, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that it granted an aggregate of 721,448 restricted share units (each an "RSU......
22.08.25 - 18:36
XFRA: EKW0: Wiederaufnahme/Resumption (XETRA)
 
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN PSYENCE GROUP INC. NEW EKW0 CA74449Q2053 AB/FROM ONWARDS 22.08.2025 18:33 CET...
22.08.25 - 17:30
Psyence Group Inc. Enters Into a Letter of Intent to Acquire Goldcoast Resource Corp. (Accesswire)
 
TORONTO, ON / ACCESS Newswire / August 22, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that it has entered into a letter of intent (the "LOI") to acquire all of the......
07.07.25 - 23:06
Psyence Group Inc. Closes Second Tranche of Non-Brokered Private Placement for Remaining Proceeds (Accesswire)
 
TORONTO, ON / ACCESS Newswire / July 7, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), is pleased to announce that it has successfully closed the second tranche ("Tranche 2") of......
25.06.25 - 23:03
PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares (GlobeNewswire EN)
 
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “Offering”) of common shares in the capital of the Company (the “Common Shares”)....
18.06.25 - 23:48
Psyence Group announces offering of up to C$600,000 non-brokered private placement of common shares (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.06.25 - 23:39
PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares (GlobeNewswire EN)
 
TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing is pleased to announce an offering of a non-brokered private placement (the “Offering”) of up to 6,000,000 common shares of the Company (the “Common Shares”) at a price of C$0.10 per Common Share for gross proceeds of up to C$600,000. No finder's fees or commissions will be payable in connection with the Offering....
27.05.25 - 13:42
Psyence Biomedical Ltd.: Psyence BioMed Finalizes Agreement with Award-Winning CRO Southern Star Research to Accelerate Phase IIb Clinical Trial (Newsfile)
 
New York, New York--(Newsfile Corp. - May 27, 2025) - Psyence BioMed (NASDAQ: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company developing nature-derived psilocybin therapies f......
23.04.25 - 09:06
XFRA: INSTRUMENT_SUSPENSION - CA74449Q2053 (XETRA)
 
Instrument ID [23657355] (EKW0 - CA74449Q2053) suspended...
23.04.25 - 09:06
XFRA: 8VC0,BC21,EKW0,1S90: Aussetzung/Suspension (XETRA)
 
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL GREAT PLAINS MET. O.N. 8VC0 CA3911731014 BAW/UFN MAGMA SILVER CORP. BC21 CA5589221004 BAW/UFN PSYENCE GROUP INC. NEW EKW0 CA74449Q2053 BAW/UFN SERES THERA.NEW DL -,001 1S90 US81750R2013 BAW/UFN...
22.04.25 - 16:39
XFRA: ISIN Change (XETRA)
 
Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA00833F3079 African Energy Metals Inc. 22.04.2025 CA5589221004 Magma Silver Corp. 23.04.2025 Tausch 1:1 CA74449Q1063 Psyence Group Inc. 22.04.2025 CA74449Q2053 Psyence Group Inc. 23.04.2025 Tausch 15:1 CA65651T1012 Great Plains Metals Corp. 22.04.2025 CA3911731014 Great Plains Metals Corp. 23.04.2025 Tausch 1:1 US81750R1023 Seres Therapeutics Inc. 22.04.2025 US81750R2013 Seres Therapeutics Inc. 23.04.2025 Tausch 20:1 CA5015067039 KWESST Micro Systems Inc. 22.04.2025 CA5015068029 KWESST Micro Systems Inc. 23.04.2025 Tausch 21:1 FI4000369657 Glaston Oyj 22.04.2025 FI4000587340 Glaston Oyj 23.04.2025 Tausch 2:1...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!